On TikTok, Reddit, and some telehealth websites, microdosing glucagon-like peptide-1 (GLP-1) receptor agonist medications is pitched as a gentler, more flexible way to use drugs such as the GLP-1 agonist semaglutide (Ozempic, Wegovy), the dual GIP/GLP-1 agonist tirzepatide (Mounjaro, Zepbound), and oral nonpeptide GLP-1 receptor agonist orforglipron (Foundayo)
Semaglutide side effects are common, especially during the first month and after dose increases, but the vast majority are temporary
Different kinds of membranes are used in filters and pore size of these membranes proves to be a physical barrier for microbes
Satoh-Asahara, N., et al
Future therapeutic strategies aimed at restoring mitochondrial homeostasis may hold promise for reducing vascular aging
Ozma MA, Abbasi A, Akrami S, Lahouty M, Shahbazi N, Ganbarov K, Pagliano P, Sabahi S, Kse , Yousefi M (2022) Postbiotics as the key mediators of the gut microbiota-host interactions